- Home
- BQ vs MYNZ Comparison
BQ vs MYNZ Comparison
Compare BQ & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BQ | MYNZ |
|---|---|---|
| Founded | 2008 | 2021 |
| Country | China | Germany |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.4M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BQ | MYNZ |
|---|---|---|
| Price | $1.13 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 95.7K | ★ 271.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.08 | $0.55 |
| 52 Week High | $72.74 | $5.61 |
Technical Indicators
Market Signals| Indicator | BQ | MYNZ |
|---|---|---|
| Relative Strength Index (RSI) | 29.71 | 43.20 |
| Support Level | N/A | $0.60 |
| Resistance Level | $2.34 | $1.69 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 8.79 | 59.72 |
Price Performance
Historical ComparisonAbout BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.